Article Information
History
- July 9, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00290, Finland
- 2Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China
- 3Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, 00290, Finland
- ↵*Corresponding author: Jing Tang, jing.tang{at}helsinki.fi